デフォルト表紙
市場調査レポート
商品コード
1667795

単純ヘルペスウイルス治療の世界市場レポート 2025年

Herpes Simplex Virus Treatment Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
単純ヘルペスウイルス治療の世界市場レポート 2025年
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

単純ヘルペスウイルス治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5%で34億1,000万米ドルに成長します。予測期間の成長は、抗ウイルス療法の進歩、予防対策の重視、ワクチン開発の可能性、遠隔医療と遠隔診察、世界ヘルスへの取り組みなどに起因すると考えられます。予測期間の主な動向には、ナノテクノロジーの導入、遠隔診察のための遠隔医療、自然療法とハーブ療法、新生児ヘルペス予防戦略、抗ウイルス薬耐性モニタリングなどがあります。

性感染症(STI)の増加率は、将来的に単純ヘルペスウイルス(HSV)治療市場の拡大を促進すると予想されています。STI(性感染症)とは、特定の細菌やウイルス、その他の微生物の感染によって引き起こされる疾患で、感染者との性行為中に血液や精液、膣液、その他の体液を介して感染します。HSV治療は、主に尿道炎、子宮頸管炎、性器潰瘍につながる感染症などの性感染症に対処するものです。例えば、2024年3月、英国議会はSTIの顕著な増加を報告し、淋病の診断が41.3%増加し、2021年の27,545人から2022年には38,923人に急増したことを強調しました。同様に、クラミジア症例は25.3%増加し、15,267例から19,129例に増加し、同時期に感染性梅毒症例は12.9%増加し、5,316例から6,003例に増加しました。このように、STI有病率の増加がHSV治療市場の成長に拍車をかけています。

都市化は単純ヘルペスウイルス治療市場の成長の原動力になると予想されます。都市化は、経済開発と工業化によって促進されるプロセスであり、農村部を都市中心部に変貌させる。都市部におけるHSV治療の普及は、人口密度の向上、ヘルスケアへのアクセスの改善、意識の向上などに起因しており、都市環境におけるウイルスの蔓延を抑制するためのより現実的な選択肢となっています。世界銀行グループの2023年4月の推計によると、世界人口の半分以上が都市部に居住しており、この都市人口は2045年までに1.5倍の60億人に増加すると予測されています。したがって、都市化は単純ヘルペスウイルス治療市場を牽引する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界単純ヘルペスウイルス治療PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の単純ヘルペスウイルス治療市場:成長率分析
  • 世界の単純ヘルペスウイルス治療市場の実績:規模と成長, 2019-2024
  • 世界の単純ヘルペスウイルス治療市場の予測:規模と成長, 2024-2029, 2034F
  • 世界単純ヘルペスウイルス治療総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の単純ヘルペスウイルス治療市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 単純ヘルペスウイルス1型感染症
  • 単純ヘルペスウイルス2型感染症
  • 世界の単純ヘルペスウイルス治療市場薬の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • アシクロビル
  • バラシクロビル
  • ファムシクロビル
  • その他の薬物
  • 世界の単純ヘルペスウイルス治療市場:投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オーラル
  • 注射
  • 話題
  • 世界の単純ヘルペスウイルス治療市場ワクチンによって、実績と予測, 2019-2024, 2024-2029F, 2034F
  • シンプリリックス
  • その他のワクチン
  • 世界の単純ヘルペスウイルス治療市場:流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • ドラッグストア
  • 小売薬局
  • オンラインプロバイダー
  • 世界の単純ヘルペスウイルス治療市場、単純ヘルペスウイルス1型感染症のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 口腔ヘルペス
  • 口唇ヘルペス
  • 口唇ヘルペス
  • 世界の単純ヘルペスウイルス治療市場、単純ヘルペスウイルス2型感染症のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 性器ヘルペス
  • 新生児ヘルペス
  • その他の合併症

第7章 地域別・国別分析

  • 世界の単純ヘルペスウイルス治療市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の単純ヘルペスウイルス治療市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 単純ヘルペスウイルス治療市場:競合情勢
  • 単純ヘルペスウイルス治療市場:企業プロファイル
    • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • Carlsbad Technology Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Glenmark Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Mylan N.V.
  • Teva Pharmaceuticals Industries Ltd.
  • Sanofi S.A.
  • Novartis AG
  • Zydus Pharmaceuticals Inc.
  • Abbott Laboratories
  • Amneal Pharmaceuticals Inc.
  • Pfizer Inc.
  • Viatris Inc.
  • Agenus Inc.
  • Merck KGaA
  • Chimerix Inc.
  • Avet Pharmaceuticals Inc.
  • EPI Health LLC
  • Bristol Myers Squibb Company

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 単純ヘルペスウイルス治療市場2029:新たな機会を提供する国
  • 単純ヘルペスウイルス治療市場2029:新たな機会を提供するセグメント
  • 単純ヘルペスウイルス治療市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r24200

Herpes simplex virus treatment involves addressing infections caused by the herpes simplex virus (HSV), commonly known as herpes, which can result in painful blisters or ulcers. This treatment aims to manage the symptoms of the viral infection through the use of antiviral creams or tablets.

The main types of herpes simplex virus treatment are for herpes simplex virus-1 infection and herpes simplex virus-2 infection. Herpes simplex virus type 1 (HSV-1) belongs to the Alphaherpesviridae subfamily, characterized by a linear double-stranded DNA virus. The various drugs used for treatment include acyclovir, valacyclovir, famciclovir, and others. Treatment can be administered through oral, injection, or topical routes. Several types of vaccines, including Simplirix and others, are available and sold through various distribution channels such as hospital pharmacies, drug stores, retail pharmacies, and online providers.

The herpes simplex virus treatment market research report is one of a series of new reports from The Business Research Company that provides herpes simplex virus treatment market statistics, including herpes simplex virus treatment industry global market size, regional shares, competitors with a herpes simplex virus treatment market share, detailed herpes simplex virus treatment market segments, market trends and opportunities, and any further data you may need to thrive in the herpes simplex virus treatment industry. This herpes simplex virus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The herpes simplex virus treatment market size has grown strongly in recent years. It will grow from$2.41 billion in 2024 to $2.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to the increased prevalence of HSV infections, antiviral medications development, clinical research and drug approvals, patient education and awareness, and global efforts for std prevention

The herpes simplex virus treatment market size is expected to see strong growth in the next few years. It will grow to $3.41 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to advancements in antiviral therapies, focus on preventive measures, potential vaccine development, telemedicine and remote consultations, global health initiatives. Major trends in the forecast period include incorporation of nanotechnology, telemedicine for remote consultations, natural and herbal therapies, strategies for neonatal herpes prevention, antiviral drug resistance monitoring.

The rising rates of sexually transmitted infections (STIs) are anticipated to drive the expansion of the herpes simplex virus (HSV) treatment market in the future. STIs, or sexually transmitted diseases (STDs), are illnesses caused by infections with specific bacteria, viruses, or other microorganisms that can be transmitted through blood, semen, vaginal fluids, or other body fluids during sexual activity with an infected individual. HSV treatment primarily addresses sexually transmitted conditions such as urethritis, cervicitis, and infections leading to genital ulcers. For example, in March 2024, the UK Parliament reported a notable increase in STIs, highlighting a 41.3% rise in gonorrhea diagnoses, which jumped from 27,545 in 2021 to 38,923 in 2022. Similarly, chlamydia cases saw a 25.3% increase, rising from 15,267 to 19,129, while infectious syphilis cases grew by 12.9%, from 5,316 to 6,003 during the same timeframe. Thus, the increase in STI prevalence is fueling the growth of the HSV treatment market.

Urbanization is expected to be a driving force behind the growth of the herpes simplex virus treatment market. Urbanization, a process fueled by economic development and industrialization, transforms rural areas into urban centers. The prevalence of HSV treatment in urban populations is attributed to higher population density, improved healthcare accessibility, and increased awareness, making it a more viable option for controlling the virus's spread in urban settings. According to the World Bank Group's April 2023 estimates, over half of the global population resides in urban areas, and this urban population is projected to grow to 6 billion, marking a 1.5 times increase by 2045. Therefore, urbanization is a significant factor driving the herpes simplex virus treatment market.

A notable trend gaining traction in the herpes simplex virus treatment market is the innovation of HSV treatments. Major companies in the market are actively engaged in developing new treatments and drugs to maintain their market position. For instance, in October 2022, Replay Therapeutics, a US-based genome writing company, introduced Eudora, its first HSV gene therapy company focusing on retinal eye disease. Eudora is the first product using synHSVTM, a high-payload-capacity HSV delivery vector, within Replay's distinct corporate structure that separates the development of technological and medicinal products. This innovative approach aims to address monogenic brain, skin, and muscle illnesses using big DNA gene therapy.

Leading companies in the herpes simplex virus treatment market are directing their efforts toward developing advanced tests, such as chip-based RT-PCR tests, to meet the demand for efficient diagnostic solutions and enhance market profitability. The chip-based RT-PCR test utilizes microchip technology for rapid and efficient nucleic acid amplification through reverse transcription-polymerase chain reaction. In January 2023, Molbio Diagnostics, an India-based molecular diagnostics manufacturer, launched Truenat HSV 1/2, a chip-based RT-PCR test approved by CDSCO for swift herpes diagnosis. This test, compatible with the Truelab infrastructure, provides sample-to-results in an hour without additional setup, employing real-time PCR technology to distinguish between HSV-1 and HSV-2, aiding in the prompt detection of oral and genital herpes.

In April 2023, SK Capital acquired Apotex Pharmaceutical Holdings Inc for an undisclosed amount, aiming to leverage Apotex's iconic brand, extensive product portfolio, international presence, and skilled team to establish itself as a leading global player in the pharmaceutical industry. Apotex Pharmaceutical Holdings, based in Canada, is a pharmaceutical company providing tablets for herpes virus treatment.

Major companies operating in the herpes simplex virus treatment market include GlaxoSmithKline plc, Carlsbad Technology Inc., Glenmark Pharmaceuticals Ltd., Fresenius Kabi AG, Apotex Inc., Mylan N.V., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Novartis AG, Zydus Pharmaceuticals Inc., Abbott Laboratories, Amneal Pharmaceuticals Inc., Pfizer Inc., Viatris Inc., Agenus Inc., Merck KGaA, Chimerix Inc., Avet Pharmaceuticals Inc., EPI Health LLC, Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Johnson & Johnson, AbbVie Inc., AstraZeneca plc, Gilead Sciences Inc., Bayer AG, Eli Lilly and Company, BioCryst Pharmaceuticals Inc., AiCuris Anti-infective Cures GmbH, CureVac AG

North America was the largest region in the herpes simplex virus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global herpes simplex virus treatment market report during the forecast period. The regions covered in the herpes simplex virus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the herpes simplex virus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The herpes simplex virus treatment market consists of sales of docosanol and penciclovir. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Herpes Simplex Virus Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on herpes simplex virus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for herpes simplex virus treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The herpes simplex virus treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Herpes Simplex Virus-1 Infection; Herpes Simplex Virus-2 Infection
  • 2) By Drug Type: Acyclovir; Valacyclovir; Famciclovir; Other Drugs
  • 3) By Route Of Administration: Oral; Injection; Topical
  • 4) By Vaccine: Simplirix; Other Vaccines
  • 5) By Distribution Channel: Hospital Pharmacies; Drug store; Retail Pharmacies; Online Providers
  • Subsegments:
  • 1) By Herpes Simplex Virus-1 Infection: Oral Herpes; Cold Sores; Herpes Labialis
  • 2) By Herpes Simplex Virus-2 Infection: Genital Herpes; Neonatal Herpes; Other Complications
  • Companies Mentioned: GlaxoSmithKline plc; Carlsbad Technology Inc.; Glenmark Pharmaceuticals Ltd.; Fresenius Kabi AG; Apotex Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Herpes Simplex Virus Treatment Market Characteristics

3. Herpes Simplex Virus Treatment Market Trends And Strategies

4. Herpes Simplex Virus Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Herpes Simplex Virus Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Herpes Simplex Virus Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Herpes Simplex Virus Treatment Market Growth Rate Analysis
  • 5.4. Global Herpes Simplex Virus Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Herpes Simplex Virus Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Herpes Simplex Virus Treatment Total Addressable Market (TAM)

6. Herpes Simplex Virus Treatment Market Segmentation

  • 6.1. Global Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Herpes Simplex Virus-1 Infection
  • Herpes Simplex Virus-2 Infection
  • 6.2. Global Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • Other Drugs
  • 6.3. Global Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injection
  • Topical
  • 6.4. Global Herpes Simplex Virus Treatment Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simplirix
  • Other Vaccines
  • 6.5. Global Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Drug store
  • Retail Pharmacies
  • Online Providers
  • 6.6. Global Herpes Simplex Virus Treatment Market, Sub-Segmentation Of Herpes Simplex Virus-1 Infection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Herpes
  • Cold Sores
  • Herpes Labialis
  • 6.7. Global Herpes Simplex Virus Treatment Market, Sub-Segmentation Of Herpes Simplex Virus-2 Infection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genital Herpes
  • Neonatal Herpes
  • Other Complications

7. Herpes Simplex Virus Treatment Market Regional And Country Analysis

  • 7.1. Global Herpes Simplex Virus Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Herpes Simplex Virus Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Herpes Simplex Virus Treatment Market

  • 8.1. Asia-Pacific Herpes Simplex Virus Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Herpes Simplex Virus Treatment Market

  • 9.1. China Herpes Simplex Virus Treatment Market Overview
  • 9.2. China Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Herpes Simplex Virus Treatment Market

  • 10.1. India Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Herpes Simplex Virus Treatment Market

  • 11.1. Japan Herpes Simplex Virus Treatment Market Overview
  • 11.2. Japan Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Herpes Simplex Virus Treatment Market

  • 12.1. Australia Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Herpes Simplex Virus Treatment Market

  • 13.1. Indonesia Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Herpes Simplex Virus Treatment Market

  • 14.1. South Korea Herpes Simplex Virus Treatment Market Overview
  • 14.2. South Korea Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Herpes Simplex Virus Treatment Market

  • 15.1. Western Europe Herpes Simplex Virus Treatment Market Overview
  • 15.2. Western Europe Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Herpes Simplex Virus Treatment Market

  • 16.1. UK Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Herpes Simplex Virus Treatment Market

  • 17.1. Germany Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Herpes Simplex Virus Treatment Market

  • 18.1. France Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Herpes Simplex Virus Treatment Market

  • 19.1. Italy Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Herpes Simplex Virus Treatment Market

  • 20.1. Spain Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Herpes Simplex Virus Treatment Market

  • 21.1. Eastern Europe Herpes Simplex Virus Treatment Market Overview
  • 21.2. Eastern Europe Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Herpes Simplex Virus Treatment Market

  • 22.1. Russia Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Herpes Simplex Virus Treatment Market

  • 23.1. North America Herpes Simplex Virus Treatment Market Overview
  • 23.2. North America Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Herpes Simplex Virus Treatment Market

  • 24.1. USA Herpes Simplex Virus Treatment Market Overview
  • 24.2. USA Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Herpes Simplex Virus Treatment Market

  • 25.1. Canada Herpes Simplex Virus Treatment Market Overview
  • 25.2. Canada Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Herpes Simplex Virus Treatment Market

  • 26.1. South America Herpes Simplex Virus Treatment Market Overview
  • 26.2. South America Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Herpes Simplex Virus Treatment Market

  • 27.1. Brazil Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Herpes Simplex Virus Treatment Market

  • 28.1. Middle East Herpes Simplex Virus Treatment Market Overview
  • 28.2. Middle East Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Herpes Simplex Virus Treatment Market

  • 29.1. Africa Herpes Simplex Virus Treatment Market Overview
  • 29.2. Africa Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Herpes Simplex Virus Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Herpes Simplex Virus Treatment Market Competitive Landscape
  • 30.2. Herpes Simplex Virus Treatment Market Company Profiles
    • 30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Carlsbad Technology Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Glenmark Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Herpes Simplex Virus Treatment Market Other Major And Innovative Companies

  • 31.1. Mylan N.V.
  • 31.2. Teva Pharmaceuticals Industries Ltd.
  • 31.3. Sanofi S.A.
  • 31.4. Novartis AG
  • 31.5. Zydus Pharmaceuticals Inc.
  • 31.6. Abbott Laboratories
  • 31.7. Amneal Pharmaceuticals Inc.
  • 31.8. Pfizer Inc.
  • 31.9. Viatris Inc.
  • 31.10. Agenus Inc.
  • 31.11. Merck KGaA
  • 31.12. Chimerix Inc.
  • 31.13. Avet Pharmaceuticals Inc.
  • 31.14. EPI Health LLC
  • 31.15. Bristol Myers Squibb Company

32. Global Herpes Simplex Virus Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Herpes Simplex Virus Treatment Market

34. Recent Developments In The Herpes Simplex Virus Treatment Market

35. Herpes Simplex Virus Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Herpes Simplex Virus Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Herpes Simplex Virus Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Herpes Simplex Virus Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer